Clinical evaluation of sulbactam/cefoperazone (SBT/CPZ Sulperazon) in oromaxillofacial infection and phleqmon in the fields of oral surgery.
スポンサーリンク
概要
- 論文の詳細を見る
Clincal evaluation of sulbactam/cefoperazone was carried out in 10 cases of osteitis of jaw and in 8cases of cellulitis.<BR>1. The clinical efficacy rate was 77.8 % according to the evaluation score on the 3rd day of treatment, and 72.2 % by the doctor's judgement.<BR>2. Of 14 patients who failed to respond to previous antibiotic treatments, 11 (78.6 %) were effectively treated by SBT/CPZ.<BR>3. MICs of SBT/CPZ against aerobic and anaerobic bacteria were low, and SBT/CPZ resistant strains were not found.<BR>4. As for side effects, they were moderate-some diarrhea appeared in one case. Abnormal findings in the hepatic function test were noted in 3 cases, but the changes were not clinically important.<BR>5. These results indicate the usefulness of sulbactam/cefoperazone in the treatment of odontogenic infections.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果